openPR Logo
Press release

Alzheimer’s Disease Diagnostic Market Top Players Worldwide – Industry Segmented by Size and Share with Euro-Bio Ltd (UK) and Cognition Therapeutics Inc. (US) and Forecasts by 2022

05-09-2018 03:08 PM CET | Health & Medicine

Press release from: Market Research Future

Alzheimer?s Disease Market

Alzheimer?s Disease Market

Global Alzheimer’s Disease Diagnostic Market – Overview:

The wide spread detection of Alzheimer’s disease in various areas of the world as well as its detection in diverse demographics have prompted the expansion of the sector. Market reports linked to the healthcare sector made available by Market Research Future along with published reports on other sectors have been recently issued along with a report on this market. The industry is expected to attain USD 12 billion in revenues by the end of the forecasted period while expanding at a CAGR of 10 percent in the forecast period.

The ability to detect Alzheimer’s in the initial stages can help in a major way to control the progression of the disease. However, increase in the geriatric segment of the population has increased in the number of cases that are being detected around the world. Rise in the level of medical breakthroughs made towards understanding the disease have enabled the discovery of new methods for detection. Additionally, discoveries of new drugs that can potentially control Alzheimer’s are also increasing gradually, which is beneficial for the development of this market especially through the forecast period.

Get Premium Sample Report @ https://www.marketresearchfuture.com/sample_request/2149 .

Global Alzheimer’s Disease Diagnostic Market Competitive Analysis:

Contenders who are a part of the industry have devised their corporate strategy blueprint in a way that that can bring the best outcomes for development in the current scenario. With the ability to sustain their competitive edge being one of the primary factors driving their efforts, the scope for growth in the industry appears to be promising through the forecast period. The rising affinity for diversification in the market, has indirectly enabled the players to utilize the many prospects available. The companies in this particular industry are also trying to maintain and enhance financial liquidity that can be instrumental to invest in growth strategies as and when they become available. This particular trend has empowered portfolio improvements along with the affinity for diversification in the sector, which has helped the market competitors tremendously in this industry.

The prominent contenders in the market for Alzeihmer’s disease diagnostic market are Neuro-Bio Ltd (UK), TauRx (Republic of Singapore), Accera, Inc. (US), Alector LLC (US), Treventis Corporation (US), Eli Lilly and Company (UK), Cognition Therapeutics Inc. (US) among others.

Alzheimer’s Disease Diagnostic Market Detailed Regional Analysis:

The regional analysis for Alzheimer’s disease diagnostic market includes regions such as Europe, Asia Pacific, North America and rest of the world. The North American region held the major market share in Alzheimer’s disease diagnostic globally in 2015. The North American region for Alzheimer’s disease diagnostics is anticipated to reach USD 12 Million by the end of the forecast period. The European region is the second major industry for Alzheimer’s disease diagnostic industry. The Asia Pacific is estimated to be the most rapidly growing region of the Alzheimer’s disease diagnostic industry in the forecast period.

Alzheimer’s Disease Diagnostic Industry Segments:

The industry for Alzheimer’s disease diagnostics globally on the basis of type has been segmented into late-onset Alzheimer's disease, early-onset Alzheimer's disease, familial Alzheimer's disease and more. The end users category segments the market into hospitals, clinics, diagnostic centers and others. The diagnostic test segment of the industry comprises of mini-mental state exam (MMSE), genetic testing, neurological exam, brain imaging and others.

Get Your Customized Report @ https://www.marketresearchfuture.com/enquiry/2149 .

Alzheimer’s Disease Diagnostic Industry Updates:

April 2018 A group of researchers are on the verge of developing a blood test that can spot Alzheimer's disease long before symptoms appear. The test will be exceptionally useful for scientists trying to understand and treat Alzheimer’s. A study which was made available in the EMBO Molecular Medicine journal has discovered a potential solution to this important problem. By the use of immuno-infrared sensor technology which is based on an antibody is the basis for the test’s fuctionality. The sensor is used to extract all amyloid-beta from the blood sample. The researchers can measure the comparative levels unhealthy and of healthy protein due to the dual versions of beta-amyloid that are taken in infrared light at various permitted frequencies.

Major TOC For Global Alzheimer’s Disease Diagnostic Market Research Report- Forecast to 2022:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

List Of Tables

TABLE 1 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, 2013-2022 (USD MILLION)

TABLE 2 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY TYPE, 2013-2022 (USD MILLION)

TABLE 3 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE, 2013-2022 (USD MILLION)

TABLE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS, 2013-2022 (USD MILLION)

TABLE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY REGION, 2013-2022 (USD MILLION)

Avail Prime Discount @ https://www.marketresearchfuture.com/check-discount/2149 .

List Of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ORTHOPEDIC TRAUMA DEVICE SMARKET, BY TYPE

FIGURE 4 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY DIAGNOSTICS TYPE

FIGURE 5 GLOBAL ALZHEIMER’S DISEASE DIAGNOSTIC MARKET, BY END USERS

Continued...!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alzheimer’s Disease Diagnostic Market Top Players Worldwide – Industry Segmented by Size and Share with Euro-Bio Ltd (UK) and Cognition Therapeutics Inc. (US) and Forecasts by 2022 here

News-ID: 1044828 • Views:

More Releases from Market Research Future

1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and Forecast to 2032
1 Hexene Market size, Scope, Growth Opportunities, Trends by Manufacturers and F …
1-Hexene, a key chemical intermediate primarily used in the production of polyethylene, is experiencing a significant surge in demand globally. This demand is driven by several factors, including the growing need for high-density polyethylene (HDPE) and linear low-density polyethylene (LLDPE) in various industries such as packaging, construction, and automotive. The 1 Hexene Market is estimated at US$ 0.142 billion in 2024 and is forecasted to increase rapidly at a CAGR of
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a CAGR of 9.40% during the forecast period 2032
Hydroxypropyl Methylcellulose Capsules Market Surge to Witness Huge Demand at a …
Hydroxypropyl Methylcellulose (HPMC) capsules are a popular choice in the pharmaceutical and nutraceutical industries due to their versatility, safety, and stability. These capsules are derived from cellulose, a natural polymer, and are widely used for encapsulating a variety of drugs, supplements, and vitamins. The HPMC capsules market has been experiencing steady growth over the years, driven by several key factors. Hydroxypropyl Methylcellulose Capsules Market was valued at USD 0.420 Billion in
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
Skincare Market Size, Share, Trends, Analysis, Demand 2023-2032
The Skincare Market was valued at USD 7.15 Billion in 2022. It is forecasted to increase from USD 7.54 Billion in 2023 to USD 11.58 Billion by 2032, demonstrating a compound annual growth rate (CAGR) of 5.51% between 2023 and 2032. The comprehensive scope and research methodology of the Skincare Market report lay the foundation for a detailed and insightful analysis of the industry. The report's scope encompasses a broad spectrum,
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Share, Future Growth, Forecast Research Report 2032 
Acesulfame Potassium Market Trends, Recent Developments and Technology, Size, Sh …
The wire and cable material market is a vital sector of the global economy, serving as the backbone for various industries, including telecommunications, energy, automotive, and construction. The market encompasses a wide range of materials used in the production of wires and cables, such as copper, aluminum, polymers, and insulating materials. Over the years, the market has witnessed significant evolution driven by technological advancements, regulatory changes, and shifting consumer preferences. The

All 5 Releases


More Releases for Alzheimer

Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is
Anti-β-Alzheimer Therapies Market : Consumption, Revenue, Applications With Maj …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as